ZFP36L1 and asthma: At the protein level, in human bronchial biopsies (Figure 5), ZFP36L1 showed an increase in expression in mild patients, i.e., not taking glucocorticoids, as compared to healthy controls, and a decrease in patients with severe asthma (Figure 5).